Clinical Trial Update: A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating frovatriptan for intermittent prevention of menstrually associated migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menstrually Associated Migraine

Drugs mentioned

• FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Menstrually Associated Migraine | Phase 3 | Status: COMPLETED